Expanding the molecular signatures of malignant ossifying fibromyxoid tumours with two novel gene fusions: PHF1::FOXR1 and PHF1::FOXR2.

MLA

Srivastava, Pooja, et al. “Expanding the Molecular Signatures of Malignant Ossifying Fibromyxoid Tumours with Two Novel Gene Fusions: PHF1::FOXR1 and PHF1::FOXR2.” Histopathology, vol. 82, no. 6, May 2023, pp. 946–52. EBSCOhost, https://doi.org/10.1111/his.14868.

APA

Srivastava, P., Zilla, M. L., Naous, R., Marker, D., Khoshnoodi, P., Burgess, M., Herradura, A., Wu, J., Surrey, L. F., & John, I. (2023). Expanding the molecular signatures of malignant ossifying fibromyxoid tumours with two novel gene fusions: PHF1::FOXR1 and PHF1::FOXR2. Histopathology, 82(6), 946–952. https://doi.org/10.1111/his.14868

Chicago

Srivastava, Pooja, Megan L Zilla, Rana Naous, Daniel Marker, Pooria Khoshnoodi, Melissa Burgess, Armando Herradura, Jinhua Wu, Lea F Surrey, and Ivy John. 2023. “Expanding the Molecular Signatures of Malignant Ossifying Fibromyxoid Tumours with Two Novel Gene Fusions: PHF1::FOXR1 and PHF1::FOXR2.” Histopathology 82 (6): 946–52. doi:10.1111/his.14868.